| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/26/2007 | WO2007047148A1 Minimal bacterial genome |
| 04/26/2007 | WO2007046893A2 Methods for generating bioactive assemblies and uses thereof |
| 04/26/2007 | WO2007046796A1 Peptides and methods of use |
| 04/26/2007 | WO2007046634A1 Method for preparing recombinant peptide from spider venom and analgesic composition containing the peptide |
| 04/26/2007 | WO2007045911A1 Integral membrane protein |
| 04/26/2007 | WO2007045906A1 Rfamide-related peptide precursor proteins and rfamide peptides |
| 04/26/2007 | WO2007045891A1 Kunitz domain containing protein |
| 04/26/2007 | WO2007045873A2 Medical uses and therapies based upon the action of azurocidin on igfbp-1 |
| 04/26/2007 | WO2007045690A1 Recombinant cell lines for the stable and high-level production of biologically active dkk1 protein |
| 04/26/2007 | WO2007045674A1 Production influenza virus vaccines |
| 04/26/2007 | WO2007045398A2 Novel choline oxidases with modified substrate specificity |
| 04/26/2007 | WO2007045247A2 Fibroblast growth factor receptor-derived peptides |
| 04/26/2007 | WO2007045243A2 Novel fgf receptor binding compounds comprising peptide fragments of neural cell adhesion molecule l1 |
| 04/26/2007 | WO2007045160A1 Gene cry7bal encoding an insecticidal crystal protein of bacillus thuringiensis |
| 04/26/2007 | WO2007030518A3 Conformationally stabilized hiv envelope immunogens and triggering hiv-1 envelope to reveal cryptic v3-loop epitopes |
| 04/26/2007 | WO2007027661A3 Human g protein-coupled receptor and modulators thereof for the treatment of atherosclerosis and atherosclerotic disease and for the treatment of conditions related to mcp-1 expression |
| 04/26/2007 | WO2007024668A3 Targeting of herpes simplex virus to specific receptors |
| 04/26/2007 | WO2007017277A8 METHOD FOR THE PURIFICATION OF ALPHA-1 PROTEINASE INHIBITOR (a1PI) |
| 04/26/2007 | WO2007017067A3 Modulators of the melted protein and uses thereof |
| 04/26/2007 | WO2007012944A3 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus |
| 04/26/2007 | WO2007004060A3 Cytokine receptor modulators and uses thereof |
| 04/26/2007 | WO2007003675A3 Experimental neuroinflammation model, method of obtaining same and applications thereof |
| 04/26/2007 | WO2006133795A3 A new human t-cell lymphotropic virus (htlv-3): nucleic acid and peptidic sequences thereof and method for detecting htlv-3 |
| 04/26/2007 | WO2006126096A3 Effect of porcinesheath proteins on the regeneration activity of periodontal ligament |
| 04/26/2007 | WO2006119432A3 Isolation, cloning and characterization of new adeno-associated virus (aav) serotypes |
| 04/26/2007 | WO2006110591A3 POP2 NFkB-INHIBITING POLYPEPTIDES, NUCLEIC ACIDS AND METHODS OF USE |
| 04/26/2007 | WO2006107761A3 Axmi-027, axmi-036 and axmi-038, a family of delta-endotoxin genes and methods for their use |
| 04/26/2007 | WO2006104615A3 Influenza nucleic acids, polypeptides, and uses thereof |
| 04/26/2007 | WO2006103252A3 Use of hydrophobin as a phase stabiliser |
| 04/26/2007 | WO2006102979A3 Inflammation markers and combinations thereof as biochemical markers for cardiovascular diseases |
| 04/26/2007 | WO2006042242A3 Amylin family polypeptide- 6 (afp- 6) analogs and methods of making and using them |
| 04/26/2007 | WO2005091777A3 Methods and materials relating to insulin growth factor-like (igfl) polypeptides and polynucleotides |
| 04/26/2007 | WO2005005612A3 Tag-1 and tag-2 proteins and uses thereof |
| 04/26/2007 | WO2004015082A3 Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same |
| 04/26/2007 | US20070094753 Polycomb genes from maize- Mez1 and Mez2 |
| 04/26/2007 | US20070094752 Using vector transformation to generate transgenic plants with enhanced freeze, salt and drought resistance |
| 04/26/2007 | US20070094744 A novel stay-green gene and method for preparing stay-green transgenic plants |
| 04/26/2007 | US20070093652 longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands |
| 04/26/2007 | US20070093650 Nucleic acid and proteins showing increased expression dose under salt stress |
| 04/26/2007 | US20070093649 Process for purifying interferon beta |
| 04/26/2007 | US20070093648 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 04/26/2007 | US20070093647 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics |
| 04/26/2007 | US20070093646 Crystalline vap-1 and uses thereof |
| 04/26/2007 | US20070093645 Peptide vectors |
| 04/26/2007 | US20070093536 Target protein of antidiabetic and novel antidiabetic insuful corresponding thereto |
| 04/26/2007 | US20070093441 useful to efficiently induce self-specific immune responses; comprising a virus-like particle and at least one protein, or peptide of IL-5, IL-13 and/or eotaxin |
| 04/26/2007 | US20070093438 using a nucleic acid molecule in a screening assay for the identification of antiproliferative drug, and performing a functional analysis for the spindle formation or microtubule function during cell division; small interfering RNAs |
| 04/26/2007 | US20070093436 Drop1, a novel marker for carcinogenesis |
| 04/26/2007 | US20070093427 Membrane-permeable NFAT inhibitory peptide |
| 04/26/2007 | US20070093425 Improved safety and stability and excellent percutaneous permeability; 6-(succinyl-glycyl-histidyl-lysine)ascorbic acid; cosmetics; for topical application to the skin |
| 04/26/2007 | US20070093419 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 04/26/2007 | US20070093418 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 04/26/2007 | US20070093417 Novel GLP-1 analogues linked to albumin-like agents |
| 04/26/2007 | US20070093415 polypeptide comprising amino acid sequences that interact with amyloid plaques containing amyloid beta (A beta ) peptide, useful as carrier molecules to deliver drugs and diagnostic reagents to amyloid plaques |
| 04/26/2007 | US20070093413 Histone deacetylases, and uses related thereto |
| 04/26/2007 | US20070093412 Pharmaceutical composition comprising cyclic somatostatin analogues |
| 04/26/2007 | US20070093411 Diabetic inhalant formulation including surfactant and optionally preservative, isotonicizing agent, buffer and/or excipient |
| 04/26/2007 | US20070092960 Method for high throughput volumes in the fractionation of bio-molecules by chromatographic systems |
| 04/26/2007 | US20070092959 Unaltered fibrinogen and fibronectin levels |
| 04/26/2007 | US20070092948 DNA segment encoding the enzyme inhibitor for therapy of thrombosis, blood disorders; biodrugs; genetic vaccines; monoclonal antibodies; host cells |
| 04/26/2007 | US20070092947 Methods and compositions for increasing longevity and protein yield from a cell culture |
| 04/26/2007 | US20070092946 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics |
| 04/26/2007 | US20070092944 glycosylation endproducts of polyketides, glycoproteins or polyketide-peptide substrates with microbial glycosyltransferases |
| 04/26/2007 | US20070092943 Versatile vectors for expression of foreign proteins in photosynthetic bacteria |
| 04/26/2007 | US20070092941 PRO1298 polypeptides |
| 04/26/2007 | US20070092938 Diagnostics for sars virus |
| 04/26/2007 | US20070092937 Method of producing target protein, fusion protein and gene thereof, protein consisting of partial sequence of intein and gene thereof, expression vector, and transformant |
| 04/26/2007 | US20070092933 Production of multimeric fusion proteins using a c4bp scaffold |
| 04/26/2007 | US20070092922 Taxol immunoassay |
| 04/26/2007 | US20070092918 Detection of the PC-LECTIN protein which correlates to the presence of an androgen-dependent prostate cancer cell; drug target and diagnostic marker for prostate cancer |
| 04/26/2007 | US20070092913 Methods for identifying agents that modulate GPR105 activity |
| 04/26/2007 | US20070092912 Uses of human zven antagonists |
| 04/26/2007 | US20070092910 Alcohol dehydrogenase sequences useful for developing compounds for the prevention and/or treatment of metabolic diseases |
| 04/26/2007 | US20070092887 method of repeated cycles of mutagenesis, shuffling and selection which allow for the directed molecular evolution in vitro or in vivo of proteins; generating and selecting or screening for desired nucleic acid fragments encoding mutant proteins |
| 04/26/2007 | US20070092885 Secreted proteins |
| 04/26/2007 | US20070092884 Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library: application to the detection of mycobacteria |
| 04/26/2007 | US20070092877 Bcrm-1 genes and uses thereof |
| 04/26/2007 | US20070092866 Avian adenoassociated virus and uses thereof |
| 04/26/2007 | US20070092629 Quinoa protein concentrate, production and functionality |
| 04/26/2007 | US20070092538 Immunogenic reagents from west nile virus |
| 04/26/2007 | US20070092536 Cold-adapted equine influenza viruses |
| 04/26/2007 | US20070092534 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses |
| 04/26/2007 | US20070092533 Method of preventing T cell-mediated responses by the use of the major histocompatibility complex class II analog protein (map protein) from Staphylococcus aureus |
| 04/26/2007 | US20070092530 Antibodies as T cell receptor mimics, methods of production and uses thereof |
| 04/26/2007 | US20070092529 Using gene encoding transmembrane ptorein |
| 04/26/2007 | US20070092528 Superantigen fusion protein for anti-cancer therapy and methods for the production thereof |
| 04/26/2007 | US20070092519 Method for diagnosing chronic myeloid leukemia |
| 04/26/2007 | US20070092517 Truncated memapsin 2 compositions and treatments |
| 04/26/2007 | US20070092514 Novel secreted immunomodulatory proteins and uses thereof |
| 04/26/2007 | US20070092513 Antiproliferative agents; anticancer agents; controlling excessive proliferation or migration of smooth muscle cells by treating said smooth muscle cells with an effective amount of an antagonist of a native ErbB4 receptor |
| 04/26/2007 | US20070092511 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 04/26/2007 | US20070092504 Use of agents that modulate the interaction between PD-1 and its ligands in the downmodulation of immune responses |
| 04/26/2007 | US20070092489 Use of receptor sequences for immobilizing gene vectors on surfaces |
| 04/26/2007 | US20070092485 Cytokine zalpha11 ligand |
| 04/26/2007 | US20070092484 MCP-1 splice variants and methods of using same |
| 04/26/2007 | US20070092482 Conjugates of a G-CSF moiety and a polymer |
| 04/26/2007 | US20070092448 Inhibitor screening method and atopic dermatitis-like symptom inducing method which utilizes induction of production of interleukin 18 by keratinocyte and utilization of same |
| 04/26/2007 | DE102005050732A1 New fusion protein, useful for preparation of recombinant proteins or peptides, particularly aspartate proteases and proinsulin useful in diagnostics and therapy, includes the ecotin protein and its signal sequence |
| 04/26/2007 | DE102005049637A1 Antagonisten gegen die Interaktion von PF4 und RANTES Antagonists to the interaction of PF4 and RANTES |
| 04/26/2007 | DE102004004924B4 A141S-und G399S-Mutation im Omi/HtrA2-Protein bei Morbus Parkinson A141S and G399S mutation in the Omi / HtrA2 protein in Parkinson's disease |